IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 10KSB40/A SEC Filings
Annual Report Form for Small Businesses that also have a Positive Response to Item 405: [Amend]

EPOCH PHARMACEUTICALS INC, 10KSB40/A, 1999-07-06
SANGUINE CORP, 10KSB40/A, 1996-06-17


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission